PIVOT INTERNATIONAL BLOG
Thank you for visiting the Pivot International blog. We are a collaborative product development, design, and manufacturing firm serving clients around the world. For more information about our services, please call us at 1-877-206-5001. We look forward to working with you.
When it comes to launching a new product successfully, businesses need to understand they’re building two products and two cases: one for customers and one for investors. The savviest of businesses never lose sight of which audience they’re talking to and the differences between them.
Three Winning Strategies and Competitive Insights from Star Sales Performers for Developing Successful ProductsPosted: September 24, 2020
For all the challenges that supply chain professionals, product developers, manufacturers, and companies of all kinds have faced over the last six months, the world of business can and will go on. Market opportunities must still be identified, products conceived, and product development partnerships formed.
Innovation has been a key term and area of interest in management science for well over two decades. The names of many of the world’s most noteworthy, profitable, and respected companies, including Apple, Alphabet, Amazon, and Tesla, are synonymous with this term. As it pertains to the leadership demands of successfully navigating the disruption of the global pandemic, the role of innovation is perhaps more relevant than ever.
Entrepreneurs and enterprise-level executives alike have always attempted to build businesses that are robust enough to withstand unexpected storms. For example, contingency planning is hardly a novel concept, and many leadership teams of companies large and small engage in this critical activity. But the unprecedented nature and speed, scope, and scale of COVID-19 has brought new urgency to the quest for resilience.
Before 2020, demand for telehealth services and home-care medical devices was already on the rise. But the global pandemic has driven exponential consumer adoption and skyrocketed market demand for these services and products, and Mckinsey & Company estimates the potential market for them at $250 billion in US healthcare spending.